Market Place
Sourcing Support
Ovid Therapeutics Presents Pre-Clinical Results On OV329
26 Sep 2024 //
GLOBENEWSWIRE
Pyros Pharmaceuticals Launches VIGAFYDE, Ready-to-Use Vigabatrin Solution
03 Sep 2024 //
BUSINESSWIRE
Pyros Pharma`s Vigafyde (vigabatrin) Receives Approval in the U.S
20 Jun 2024 //
FDA
Pyros Pharmaceuticals Announces FDA Approval of VIGAFYDE™
18 Jun 2024 //
BIOSPACE
Pyros Pharms New Vigabatrin Receives Approval in US
17 Jun 2024 //
FDA
Pyros Pharma Announces FDA Approval Of VIGAFYDE™ Oral Solution
17 Jun 2024 //
BUSINESSWIRE
Upsher-Smith Rare Disease Portfolio At AAN 2024
12 Apr 2024 //
PR NEWSWIRE
Pyros Pharmaceuticals Announces VIGPODER™ (vigabatrin) is Now Available
01 Apr 2024 //
BUSINESSWIRE
Pyros Announces Positive Outcome of the Procedure for Approval of VIGZIP
15 Feb 2024 //
BUSINESSWIRE
InvaGen issues Voluntary Nationwide Recall of Vigabatrin for Oral Solution
15 Dec 2023 //
PR NEWSWIRE
InvaGen Issues Voluntary Nationwide Recall of Vigabatrin for Oral Solution
09 Dec 2023 //
PR NEWSWIRE
Health Canada Issues Recall of Sabril (vigabatrin) 500 mg sachets found to contain trace amounts of another drug
19 Sep 2023 //
HEALTH CANADA
Enforcement Report - Week of September 6, 2023
06 Sep 2023 //
FDA
Enforcement Report - Week of March 8, 2023
08 Mar 2023 //
FDA
MSN`s Generic Vigabatrin Receives Approval in the U.S.
07 Sep 2022 //
FDA
Hikma`s Generic Vigabatrin Receives Approval in the U.S.
29 Aug 2022 //
FDA
Amneal Pharma`s Generic Erlotinib Hydrochloride Receives Approval in US
22 Jun 2022 //
FDA
Lupin gets USFDA nod to market generic drug
11 Mar 2022 //
ECONOMIC TIMES
Lupin`s Generic Vigabatrin Receives Approval in the U.S.
10 Mar 2022 //
FDA
Zydus gets final US FDA nod to market generic version of Vigabatrin tablets
20 Jan 2022 //
ECONOMIC TIMES
Zydus` Generic Vigabatrin Receives Approval in the U.S.
19 Jan 2022 //
FDA
Par Pharma`s Generic Isosorbide Dinitrate Receives Approval in the US
23 Nov 2021 //
FDA
Aurobindo Pharma`s Generic Vigabatrin Receives Approval In US
29 Sep 2021 //
FDA
Dexcel Pharma`s Generic Vigabatrin Receives Approval in the US
23 Sep 2021 //
FDA
Specgx LLC Generic Vigabatrin Receives Approval In US
28 Jul 2021 //
FDA
Dr. Reddy`s Laboratories Announces the Launch of Vigabatrin Tablets, USP
02 Feb 2021 //
BUSINESSWIRE
Annora Pharma`s Generic Vigabatrin Receives Approval In US
30 Jan 2021 //
FDA
Alkem Labs`s Generic Vigabatrin Receives Approval In US
05 Dec 2020 //
FDA
InvaGen Pharmaceuticals`s Generic Vigabatrin Receives Approval in US
03 Dec 2019 //
FDA
Dr Reddy`s launches generic oral anti-epileptic drug in US
21 Aug 2019 //
ECONOMICTIMES
Dr. Reddy`s Launches Vigabatrin in the US
20 Aug 2019 //
BIOSPECTRUMASIA
Dr Reddy’s gains on launch of Vigabatrin powder
19 Aug 2019 //
MONEYCONTROL
Lundbeck’s key products shine in Q2 but problems remain
14 Aug 2019 //
PMLIVE
Aucta partners with Fosun Pharma to market the FDA-approved Vigabatrin
26 Jul 2019 //
GLOBENEWSWIRE
Aucta Pharmaceuticals Announces Licensing of Vigabatrin for Oral Solution in China
25 Jul 2019 //
WORLDPHARMATODAY
Aucta Receives its First Approval & Launches Vigabatrin for Brand Name Vigadrone™
16 Jul 2019 //
GLOBENEWSWIRE
Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
21 Jun 2019 //
FIERCE PHARMA
Teva announces US launch of Vigabatrin
09 Feb 2019 //
BIOSPECTRUM
FDA approves first generic version of Sabril
21 Jan 2019 //
FDA
VIGABATRIN - Product Details for ANDA 209822
18 Jan 2019 //
FDA
FDA approves first generic version of Sabril to treat seizures
17 Jan 2019 //
FDA
FDA Approves First Generic Version of Lundbeck’s Sabril
16 Jan 2019 //
RAPS
Teva Pharms USA`s Generic Vigabatrin Receives Approval in US
14 Jan 2019 //
FDA
Dr Reddys Labs ` Generic Vigabatrin Receives Approval in US
21 Nov 2018 //
FDA
ORPHELIA Pharma`s Kigabeq (vigabatrin) receives approval in Europe
12 Oct 2018 //
EMA
Catalent to formulate vigabatrin into novel dosage form through agreement
06 Aug 2018 //
EPMMAGAZINE
CHMP recommends paediatric-use marketing authorisation for Kigabeq and Slenyto
01 Aug 2018 //
PHARMABIZ
Meeting highlights from the CHMP 23-26 July 2018
31 Jul 2018 //
EMA
Two new paediatric-use marketing authorisations recommended by CHMP
31 Jul 2018 //
EMA
Aucta Receives its First Product Approval and Launches Vigabatrin for Oral Solution Under the Brand Name Vigadrone™
16 Jul 2018 //
PRESS RELEASE
Aucta Pharma`s Generic Vigabatrin Receives Approval in US
26 Jun 2018 //
FDA
Amneal Launches Generic for Sabril®: Vigabatrin for Oral Solution, USP
02 May 2018 //
PR NEWSWIRE
Teva Pharms USA Generic Vigabatrin Receives Approval In US
25 Apr 2018 //
FDA
Aucta Receives its First Product Approval and Launches Vigabatrin
16 Apr 2018 //
GLOBENEWSWIRE
